pharma · Hemorrhoids · Persistent or Recurrent Cutaneous T-Cell Lymphoma · CTOR
CITIUS ONCOLOGY
CITIUS ONCOLOGY, INC.
CITIUS ONCOLOGY trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.
Cranford, USA HQ
2024 Founded
5 Employees
Public company Type
CTOR · NYSE Ticker
Company details
- Status
- Public
- HQ
- Cranford, USA
- Founded
- 2024
- Employees
- 5
- Programs
- 3
- Drugs
- 8
- Patents
- 0
CITIUS ONCOLOGY clinical trials
Registry index of 3 ClinicalTrials.gov studies linked to CITIUS ONCOLOGY programs — each row shows trial ID, program name, phase, status, and indication.
CITIUS ONCOLOGY trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for CITIUS ONCOLOGY.